{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T05:59:34Z","timestamp":1780984774089,"version":"3.54.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Hubei Chen Xiao-Ping Foundation for the Development of Science and Technology of Hubei Province","award":["CXPJJH122003-28"],"award-info":[{"award-number":["CXPJJH122003-28"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s10067-026-08137-4","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T02:21:30Z","timestamp":1776997290000},"page":"3295-3309","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Circ_0001185 as a novel therapeutic target for lupus nephritis according to ceRNA network comprehensive analysis"],"prefix":"10.1007","volume":"45","author":[{"given":"Siwen","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongyao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gainetdinova","family":"Emiliia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenya","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruichan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingzhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushi","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2574-6442","authenticated-orcid":false,"given":"Manshu","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"issue":"10","key":"8137_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103404","volume":"22","author":"M Xipell","year":"2023","unstructured":"Xipell M, Lledo GM, Egan AC et al (2023) From systemic lupus erythematosus to lupus nephritis: the evolving road to targeted therapies. Autoimmun Rev 22(10):103404. https:\/\/doi.org\/10.1016\/j.autrev.2023.103404","journal-title":"Autoimmun Rev"},{"key":"8137_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241210066","author":"CY Tsai","year":"2023","unstructured":"Tsai CY, Li KJ, Shen CY et al (2023) Decipher the immunopathological mechanisms and set up potential therapeutic strategies for patients with lupus nephritis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms241210066","journal-title":"Int J Mol Sci"},{"issue":"1","key":"8137_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.kint.2023.09.001","volume":"105","author":"BH Rovin","year":"2024","unstructured":"Rovin BH, Ayoub IM, Chan TM et al (2024) Executive summary of the kdigo 2024 clinical practice guideline for the management of lupus nephritis. Kidney Int 105(1):31\u201334. https:\/\/doi.org\/10.1016\/j.kint.2023.09.001","journal-title":"Kidney Int"},{"issue":"7981","key":"8137_CR4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/d41586-023-03058-7","volume":"622","author":"E Dolgin","year":"2023","unstructured":"Dolgin E (2023) Why rings of RNA could be the next blockbuster drug. Nature 622(7981):22\u201324. https:\/\/doi.org\/10.1038\/d41586-023-03058-7","journal-title":"Nature"},{"issue":"2","key":"8137_CR5","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41587-022-01393-0","volume":"41","author":"R Chen","year":"2023","unstructured":"Chen R, Wang SK, Belk JA et al (2023) Engineering circular RNA for enhanced protein production. Nat Biotechnol 41(2):262\u2013272. https:\/\/doi.org\/10.1038\/s41587-022-01393-0","journal-title":"Nat Biotechnol"},{"issue":"2","key":"8137_CR6","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.molcel.2021.11.019","volume":"82","author":"CX Liu","year":"2022","unstructured":"Liu CX, Guo SK, Nan F et al (2022) RNA circles with minimized immunogenicity as potent pkr inhibitors. Mol Cell 82(2):420-434 e6. https:\/\/doi.org\/10.1016\/j.molcel.2021.11.019","journal-title":"Mol Cell"},{"issue":"1","key":"8137_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-020-02404-8","volume":"23","author":"C Zhang","year":"2021","unstructured":"Zhang C, Gao C, Di X et al (2021) Hsa_circ_0123190 acts as a competitive endogenous RNA to regulate aplnr expression by sponging hsa-mir-483-3p in lupus nephritis. Arthritis Res Ther 23(1):24. https:\/\/doi.org\/10.1186\/s13075-020-02404-8","journal-title":"Arthritis Res Ther"},{"key":"8137_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.123783","volume":"235","author":"AA Abbas","year":"2023","unstructured":"Abbas AA, Abdulkader HA, Giordo R et al (2023) Implications and theragnostic potentials of circular RNAs in rheumatic diseases. Int J Biol Macromol 235:123783. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.123783","journal-title":"Int J Biol Macromol"},{"issue":"3","key":"8137_CR9","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1007\/s13577-023-00883-w","volume":"36","author":"H Liang","year":"2023","unstructured":"Liang H, Liu Q (2023) The role of non-coding RNA in lupus nephritis. Hum Cell 36(3):923\u2013936. https:\/\/doi.org\/10.1007\/s13577-023-00883-w","journal-title":"Hum Cell"},{"issue":"5","key":"8137_CR10","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1007\/s10753-021-01487-y","volume":"44","author":"ZQ Xu","year":"2021","unstructured":"Xu ZQ, Ding Y, Huang XY, Xiang W, He XJ (2021) Circelk4 contributes to lupus nephritis by acting as a mir-27b-3p sponge to regulate sting\/irf3\/ifn-i signaling. Inflammation 44(5):2106\u20132119. https:\/\/doi.org\/10.1007\/s10753-021-01487-y","journal-title":"Inflammation"},{"key":"8137_CR11","doi-asserted-by":"publisher","unstructured":"Luan J., C. Jiao, C. Ma, et al, (2022) Circmtnd5 participates in renal mitochondrial injury and fibrosis by sponging mir6812 in lupus nephritis. Oxid Med Cell Longev, 2769487. https:\/\/doi.org\/10.1155\/2022\/2769487","DOI":"10.1155\/2022\/2769487"},{"issue":"9","key":"8137_CR12","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/s41374-022-00788-6","volume":"2022","author":"X Miao","year":"2022","unstructured":"Miao X, Tian Y, Wu L et al (2022) Circrtn4 aggravates mesangial cell dysfunction by activating the mir-513a-5p\/fn axis in lupus nephritis. Lab Invest 2022(9):966\u2013978. https:\/\/doi.org\/10.1038\/s41374-022-00788-6","journal-title":"Lab Invest"},{"issue":"9","key":"8137_CR13","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1002\/art.39219","volume":"67","author":"P Costa-Reis","year":"2015","unstructured":"Costa-Reis P, Russo PA, Zhang Z et al (2015) The role of micrornas and human epidermal growth factor receptor 2 in proliferative lupus nephritis. Arthritis Rheumatol 67(9):2415\u201326. https:\/\/doi.org\/10.1002\/art.39219","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"8137_CR14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.kint.2023.03.030","volume":"2023","author":"EJ Yoo","year":"2023","unstructured":"Yoo EJ, Oh KH, Piao H et al (2023) Macrophage transcription factor tonebp promotes systemic lupus erythematosus and kidney injury via damage-induced signaling pathways. Kidney Int 2023(1):163\u2013180. https:\/\/doi.org\/10.1016\/j.kint.2023.03.030","journal-title":"Kidney Int"},{"issue":"7","key":"8137_CR15","doi-asserted-by":"publisher","first-page":"869","DOI":"10.2215\/CJN.0000000000000185","volume":"2023","author":"C Zhang","year":"2023","unstructured":"Zhang C, Han X, Jin Y et al (2023) Pathogenic gene spectrum and clinical implication in Chinese patients with lupus nephritis. Clin J Am Soc Nephrol 2023(7):869\u2013880. https:\/\/doi.org\/10.2215\/CJN.0000000000000185","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"8137_CR16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11926-021-01048-0","volume":"2022","author":"TK Nowling","year":"2022","unstructured":"Nowling TK (2022) Mesangial cells in lupus nephritis. Curr Rheumatol Rep 2022(12):83. https:\/\/doi.org\/10.1007\/s11926-021-01048-0","journal-title":"Curr Rheumatol Rep"},{"issue":"5","key":"8137_CR17","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1007\/s12026-022-09296-7","volume":"2022","author":"R Fakhfakh","year":"2022","unstructured":"Fakhfakh R, Zian Z, Elloumi N et al (2022) Th17 and th1 cells in systemic lupus erythematosus with focus on lupus nephritis. Immunol Res 2022(5):644\u2013653. https:\/\/doi.org\/10.1007\/s12026-022-09296-7","journal-title":"Immunol Res"},{"issue":"2","key":"8137_CR18","doi-asserted-by":"publisher","first-page":"151","DOI":"10.4149\/gpb_2022005","volume":"41","author":"XQ Sun","year":"2022","unstructured":"Sun XQ, Liu WS, Zhang HM et al (2022) Traf3 plays a role in lupus nephritis by regulating th17 cell and treg cell balance as well as nf-kappab signaling pathway in mice. Gen Physiol Biophys 41(2):151\u2013158. https:\/\/doi.org\/10.4149\/gpb_2022005","journal-title":"Gen Physiol Biophys"},{"issue":"7","key":"8137_CR19","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1038\/s41423-020-00540-4","volume":"2021","author":"K Ma","year":"2021","unstructured":"Ma K, Du W, Xiao F et al (2021) Il-17 sustains the plasma cell response via p38-mediated bcl-xl rna stability in lupus pathogenesis. Cell Mol Immunol 2021(7):1739\u20131750. https:\/\/doi.org\/10.1038\/s41423-020-00540-4","journal-title":"Cell Mol Immunol"},{"issue":"Suppl 2","key":"8137_CR20","doi-asserted-by":"publisher","first-page":"ii3","DOI":"10.1093\/rheumatology\/keab024","volume":"2021","author":"FR Spinelli","year":"2021","unstructured":"Spinelli FR, Colbert RA, Gadina M (2021) Jak1: Number one in the family; number one in inflammation? Rheumatology (Oxford) 2021(Suppl 2):ii3\u2013ii10. https:\/\/doi.org\/10.1093\/rheumatology\/keab024","journal-title":"Rheumatology (Oxford)"},{"key":"8137_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11745","author":"RE Twomey","year":"2024","unstructured":"Twomey RE, Perper SJ, Westmoreland SV et al (2024) Therapeutic jak1 inhibition reverses lupus nephritis in a mouse model and demonstrates transcriptional changes consistent with human disease. ACR Open Rheumatol. https:\/\/doi.org\/10.1002\/acr2.11745","journal-title":"ACR Open Rheumatol"},{"issue":"10","key":"8137_CR22","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1080\/13543784.2023.2264172","volume":"32","author":"S Nakayamada","year":"2023","unstructured":"Nakayamada S, Tanaka Y (2023) Novel jak inhibitors under investigation for systemic lupus erythematosus: - where are we now? Expert Opin Investig Drugs 32(10):901\u2013908. https:\/\/doi.org\/10.1080\/13543784.2023.2264172","journal-title":"Expert Opin Investig Drugs"},{"issue":"12","key":"8137_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103440","volume":"22","author":"L Ma","year":"2023","unstructured":"Ma L, Peng L, Zhao J et al (2023) Efficacy and safety of janus kinase inhibitors in systemic and cutaneous lupus erythematosus: a systematic review and meta-analysis. Autoimmun Rev 22(12):103440. https:\/\/doi.org\/10.1016\/j.autrev.2023.103440","journal-title":"Autoimmun Rev"},{"issue":"1","key":"8137_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14881","volume":"33","author":"M Li","year":"2024","unstructured":"Li M, Weng L, Yu D, Yang G, Hao J (2024) Increased formation of neutrophil extracellular traps induced by autophagy and identification of autophagy-related biomarkers in systemic lupus erythematosus. Exp Dermatol 33(1):e14881. https:\/\/doi.org\/10.1111\/exd.14881","journal-title":"Exp Dermatol"},{"key":"8137_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116349","volume":"310","author":"C Cheng","year":"2023","unstructured":"Cheng C, Zhu R, Liu M et al (2023) Kunxian capsule alleviates renal damage by inhibiting the jak1\/stat1 pathway in lupus nephritis. J Ethnopharmacol 310:116349. https:\/\/doi.org\/10.1016\/j.jep.2023.116349","journal-title":"J Ethnopharmacol"},{"key":"8137_CR26","doi-asserted-by":"publisher","first-page":"175823","DOI":"10.1016\/j.ejphar.2023.175823","volume":"953","author":"T Ding","year":"2023","unstructured":"Ding T, Yi T, Li Y et al (2023) Luteolin attenuates lupus nephritis by regulating macrophage oxidative stress via hif-1alpha pathway. Eur J Pharmacol 953:175823. https:\/\/doi.org\/10.1016\/j.ejphar.2023.175823","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"8137_CR27","doi-asserted-by":"publisher","first-page":"e2250319","DOI":"10.1002\/eji.202250319","volume":"53","author":"GM Moneta","year":"2023","unstructured":"Moneta GM, Bracaglia C, Caiello I et al (2023) Persistently active interferon-gamma pathway and expansion of t-bet(+) b cells in a subset of patients with childhood-onset systemic lupus erythematosus. Eur J Immunol 53(7):e2250319. https:\/\/doi.org\/10.1002\/eji.202250319","journal-title":"Eur J Immunol"},{"key":"8137_CR28","doi-asserted-by":"publisher","unstructured":"Skopelja-Gardner S., J. Tai, X. Sun, et al, (2021) Acute skin exposure to ultraviolet light triggers neutrophil-mediated kidney inflammation. Proc Natl Acad Sci U S A, 118(3). https:\/\/doi.org\/10.1073\/pnas.2019097118","DOI":"10.1073\/pnas.2019097118"},{"issue":"1","key":"8137_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-023-00518-w","volume":"28","author":"W Sun","year":"2023","unstructured":"Sun W, Zhou S, Peng L et al (2023) Circznf609 regulates pulmonary fibrosis via mir-145-5p\/klf4 axis and its translation function. Cell Mol Biol Lett 28(1):105. https:\/\/doi.org\/10.1186\/s11658-023-00518-w","journal-title":"Cell Mol Biol Lett"},{"issue":"7995","key":"8137_CR30","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41586-023-06834-7","volume":"625","author":"D Huang","year":"2024","unstructured":"Huang D, Zhu X, Ye S et al (2024) Tumour circular rnas elicit anti-tumour immunity by encoding cryptic peptides. Nature 625(7995):593\u2013602. https:\/\/doi.org\/10.1038\/s41586-023-06834-7","journal-title":"Nature"},{"key":"8137_CR31","doi-asserted-by":"publisher","unstructured":"Sun M., Y. Yang, (2023) Biological functions and applications of circrnas-next generation of rna-based therapy. J Mol Cell Biol, 15(5). https:\/\/doi.org\/10.1093\/jmcb\/mjad031","DOI":"10.1093\/jmcb\/mjad031"},{"key":"8137_CR32","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ncrna.2024.09.006","volume":"10","author":"M Hashemi","year":"2025","unstructured":"Hashemi M, Khosroshahi EM, Daneii P et al (2025) Emerging roles of circrna-mirna networks in cancer development and therapeutic response. Non-coding RNA Res 10:98\u2013115. https:\/\/doi.org\/10.1016\/j.ncrna.2024.09.006","journal-title":"Non-coding RNA Res"},{"issue":"1","key":"8137_CR33","doi-asserted-by":"publisher","first-page":"2309607","DOI":"10.1080\/07853890.2024.2309607","volume":"56","author":"R Yao","year":"2024","unstructured":"Yao R, Xu L, Cheng G et al (2024) Elevated expression of hsa_circ_0000479 in neutrophils correlates with features of systemic lupus erythematosus. Ann Med 56(1):2309607. https:\/\/doi.org\/10.1080\/07853890.2024.2309607","journal-title":"Ann Med"},{"issue":"8","key":"8137_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107325","volume":"26","author":"M Song","year":"2023","unstructured":"Song M, Wang X, Gao J et al (2023) Circifngr2 regulating ankylosing spondylitis-associated inflammation through macrophage polarization. iScience 26(8):107325. https:\/\/doi.org\/10.1016\/j.isci.2023.107325","journal-title":"iScience"},{"issue":"1","key":"8137_CR35","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1080\/10985549.2022.2160605","volume":"43","author":"X Chen","year":"2023","unstructured":"Chen X, Ren X, E J, Zhou Y, Bian R (2023) Exosome-transmitted circifngr2 modulates ovarian cancer metastasis via mir-378\/st5 axis. Mol Cell Biol 43(1):22\u201342. https:\/\/doi.org\/10.1080\/10985549.2022.2160605","journal-title":"Mol Cell Biol"},{"issue":"1","key":"8137_CR36","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41419-022-05536-8","volume":"14","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Zheng Y, Liu J et al (2023) Circifngr2 enhances proliferation and migration of crc and induces cetuximab resistance by indirectly targeting kras via sponging to mir-30b. Cell Death Dis 14(1):24. https:\/\/doi.org\/10.1038\/s41419-022-05536-8","journal-title":"Cell Death Dis"},{"key":"8137_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ncrna10050049","author":"H Yuan","year":"2024","unstructured":"Yuan H, Liao X, Hu D, Guan D, Tian M (2024) Back to the origin: mechanisms of circrna-directed regulation of host genes in human disease. Non-Coding RNA. https:\/\/doi.org\/10.3390\/ncrna10050049","journal-title":"Non-Coding RNA"},{"issue":"2","key":"8137_CR38","doi-asserted-by":"publisher","first-page":"e716","DOI":"10.1002\/ctm2.716","volume":"12","author":"Y Xia","year":"2022","unstructured":"Xia Y, Zhang Q, Ye Y et al (2022) Melatonergic signalling instructs transcriptional inhibition of ifngr2 to lessen interleukin-1beta-dependent inflammation. Clin Transl Med 12(2):e716. https:\/\/doi.org\/10.1002\/ctm2.716","journal-title":"Clin Transl Med"},{"issue":"7","key":"8137_CR39","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/s41590-019-0398-x","volume":"20","author":"A Arazi","year":"2019","unstructured":"Arazi A, Rao DA, Berthier CC et al (2019) The immune cell landscape in kidneys of patients with lupus nephritis. Nat Immunol 20(7):902\u2013914. https:\/\/doi.org\/10.1038\/s41590-019-0398-x","journal-title":"Nat Immunol"},{"issue":"9","key":"8137_CR40","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.34067\/KID.0000000000000531","volume":"5","author":"I Chernova","year":"2024","unstructured":"Chernova I (2024) Lupus nephritis: immune cells and the kidney microenvironment. Kidney360 5(9):1394\u20131401. https:\/\/doi.org\/10.34067\/KID.0000000000000531","journal-title":"Kidney360"},{"issue":"5","key":"8137_CR41","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1136\/ard-2023-224788","volume":"83","author":"W Chen","year":"2024","unstructured":"Chen W, Jin B, Cheng C et al (2024) Single-cell profiling reveals kidney cd163(+) dendritic cell participation in human lupus nephritis. Ann Rheum Dis 83(5):608\u2013623. https:\/\/doi.org\/10.1136\/ard-2023-224788","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"8137_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2023.101865","volume":"37","author":"A Askanase","year":"2023","unstructured":"Askanase A, Khalili L, Tang W et al (2023) New and future therapies: changes in the therapeutic armamentarium for sle. Best Pract Res Clin Rheumatol 37(4):101865. https:\/\/doi.org\/10.1016\/j.berh.2023.101865","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"3","key":"8137_CR43","doi-asserted-by":"publisher","first-page":"331","DOI":"10.11817\/j.issn.1672-7347.2024.230508","volume":"49","author":"R Xu","year":"2024","unstructured":"Xu R, Zhang Y, Cao Q et al (2024) Imbalance of programmed cell death patterns mediated by dendritic cell subsets in systemic lupus erythematosus and lupus nephritis. Zhong Nan Da Xue Xue Bao Yi Xue Ban 49(3):331\u2013348. https:\/\/doi.org\/10.11817\/j.issn.1672-7347.2024.230508","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"issue":"754","key":"8137_CR44","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adl3848","volume":"16","author":"HR Waterman","year":"2024","unstructured":"Waterman HR, Dufort MJ, Posso SE et al (2024) Lupus iga1 autoantibodies synergize with igg to enhance plasmacytoid dendritic cell responses to rna-containing immune complexes. Sci Transl Med 16(754):eadl3848. https:\/\/doi.org\/10.1126\/scitranslmed.adl3848","journal-title":"Sci Transl Med"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08137-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08137-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08137-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T05:25:33Z","timestamp":1780982733000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-08137-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["8137"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08137-4","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"28 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the First Affiliated Hospital of Harbin Medical University (August 25, 2023\/2023JS42).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}